Important: After listening to the podcast, you will need to visit myCME to complete the post-assessment and evaluation and to claim your credits and certificate for this activity. Please go to www.mycme.com/allergy1 on any browser to complete the activity. Hypersensitivity reactions to nonsteroidal anti-inflammatory drugs (NSAIDs) are some of the most common drug reactions encountered in clinical practice. This program presents a practical approach to the evaluation and treatment of patients with NSAID allergies. This activity is designed for Allergists/Immunologists, as well as internists and primary care clinicians. This activity is not commercially supported. At the conclusion of this activity, participants should be better able to: Recognize and differentiate between the four common types of acute NSAID-induced reactions Describe the diagnostic evaluation for NSAID-induced reactions Assess the safety of selective COX-2 inhibitors in patients reporting NSAID allergy Discuss the role, safety, and efficacy of aspirin desensitization in patients with significant underlying pulmonary and cardiovascular disease Explain the current understanding of the mechanisms of NSAID-induced reactions Speaker Katherine Cahill, MD Assistant Professor of Medicine Medical Director of Clinical Asthma Research Vanderbilt University Medical Center. Nashville, TN Dr. Cahill serves as an advisor for AstraZeneca, Blueprint Medicines Corporation, Genentech, a member of the Roche Group, GlaxoSmithKline Pharmaceuticals Ltd, Novartis Pharmaceuticals Corp., and Sanofi. She is also a consultant for Ribon Therapeutics, Inc., Third Harmonic Bio, Inc., and Verantos, Inc. All of the relevant financial relationships listed for this individual have been mitigated.
Important: After listening to the podcast, you will need to visit myCME to complete the post-assessment and evaluation and to claim your credits and certificate for this activity. Please go to www.mycme.com/allergy1 on any browser to complete the activity.
Hypersensitivity reactions to nonsteroidal anti-inflammatory drugs (NSAIDs) are some of the most common drug reactions encountered in clinical practice. This program presents a practical approach to the evaluation and treatment of patients with NSAID allergies.
This activity is designed for Allergists/Immunologists, as well as internists and primary care clinicians.
This activity is not commercially supported.
At the conclusion of this activity, participants should be better able to:
Recognize and differentiate between the four common types of acute NSAID-induced reactions
Describe the diagnostic evaluation for NSAID-induced reactions
Assess the safety of selective COX-2 inhibitors in patients reporting NSAID allergy
Discuss the role, safety, and efficacy of aspirin desensitization in patients with significant underlying pulmonary and cardiovascular disease
Explain the current understanding of the mechanisms of NSAID-induced reactions
Speaker
Katherine Cahill, MD
Assistant Professor of Medicine
Medical Director of Clinical Asthma Research
Vanderbilt University Medical Center.
Nashville, TN
Dr. Cahill serves as an advisor for AstraZeneca, Blueprint Medicines Corporation, Genentech, a member of the Roche Group, GlaxoSmithKline Pharmaceuticals Ltd, Novartis Pharmaceuticals Corp., and Sanofi. She is also a consultant for Ribon Therapeutics, Inc., Third Harmonic Bio, Inc., and Verantos, Inc.
All of the relevant financial relationships listed for this individual have been mitigated.